Duration of Empirical Therapy in Neonatal Bacterial Meningitis with Third Generation Cephalosporin: a Multicenter Retrospective Study

Overview

Journal Arch Med Sci

Specialty General Medicine

Date 2019 Nov 22

PMID 31749877

Citations 2

Authors

Zhi Zhao

Xueying Hua

Jialin Yu

Haibo Zhang

Juhua Li

Zhankui Li

Affiliations

Soon will be listed here.

Abstract

Introduction: The duration of treatment is not well established, especially in the negative cerebrospinal fluid (CSF) culture. The aim of this study is to explore the influence of duration of treatment in neonatal bacterial meningitis.

Material And Methods: This is a retrospective analysis of 200 CSF specimens. Two hundred full-term neonates with bacterial meningitis admitted to the clinical status were evaluated using the Glasgow Outcome Scale (GOS) on the day of discharge.

Results: Neonates were identified as having bacterial meningitis based on the results of CSF culture tests of all suspected cases. According to the GOS, neonates were divided into two outcome groups: 77.5% good (GOS = 5) (shorter than 3 weeks' administration) and 22.5% unfavorable (GOS = 1-4) (longer than 3 weeks' administration). The duration of antibiotic treatment ranged from 4 to 43 days, and the mean therapy time was 19.74 ±7.32 days. Duration longer than 3 weeks for neonatal bacterial meningitis with negative CSF culture had no impact on prognosis. The unfavorable outcome group had more prenatal infections and premature rupture of membranes cases than the good outcome group. High CSF protein and CSF glucose and CSF cell count increase were associated with unfavorable outcome in 167 non-prenatal infection infants. High CSF cell count increase was associated with unfavorable outcome in 33 prenatal infection infants. In term infants, the positive rate of blood cultures was 24.5%.

Conclusions: Third generation cephalosporin therapy does not have a different prognosis for negative CSF culture of neonatal bacterial meningitis in term infants in this study.

Citing Articles

Coagulase-negative staphylococci (CoNS) meningitis: a narrative review of the literature from 2000 to 2020.

Azimi T, Mirzadeh M, Sabour S, Nasser A, Fallah F, Pourmand M New Microbes New Infect. 2020; 37:100755.

PMID: 33014383 PMC: 7522803. DOI: 10.1016/j.nmni.2020.100755.

Post-Traumatic Meningitis Is a Diagnostic Challenging Time: A Systematic Review Focusing on Clinical and Pathological Features.

La Russa R, Maiese A, Di Fazio N, Morano A, Di Bonaventura C, De Matteis A Int J Mol Sci. 2020; 21(11).

PMID: 32532024 PMC: 7312088. DOI: 10.3390/ijms21114148.

References

Furyk J, Swann O, Molyneux E . Systematic review: neonatal meningitis in the developing world. Trop Med Int Health. 2011; 16(6):672-9. DOI: 10.1111/j.1365-3156.2011.02750.x. View

Kuppala V, Meinzen-Derr J, Morrow A, Schibler K . Prolonged initial empirical antibiotic treatment is associated with adverse outcomes in premature infants. J Pediatr. 2011; 159(5):720-5. PMC: 3193552. DOI: 10.1016/j.jpeds.2011.05.033. View

Cohen-Wolkowiez M, Moran C, Benjamin D, Cotten C, Clark R, Benjamin Jr D . Early and late onset sepsis in late preterm infants. Pediatr Infect Dis J. 2009; 28(12):1052-6. PMC: 2798577. DOI: 10.1097/inf.0b013e3181acf6bd. View

Shlaes D, Gerding D, John Jr J, Craig W, Bornstein D, Duncan R . Society for Healthcare Epidemiology of America and Infectious Diseases Society of America Joint Committee on the Prevention of Antimicrobial Resistance: guidelines for the prevention of antimicrobial resistance in hospitals. Clin Infect Dis. 1997; 25(3):584-99. DOI: 10.1086/513766. View

Karageorgopoulos D, Valkimadi P, Kapaskelis A, Rafailidis P, Falagas M . Short versus long duration of antibiotic therapy for bacterial meningitis: a meta-analysis of randomised controlled trials in children. Arch Dis Child. 2009; 94(8):607-14. DOI: 10.1136/adc.2008.151563. View

Gowin E, Wysocki J, Avonts D, Januszkiewicz-Lewandowska D, Michalak M . Usefulness of inflammatory biomarkers in discriminating between bacterial and aseptic meningitis in hospitalized children from a population with low vaccination coverage. Arch Med Sci. 2016; 12(2):408-14. PMC: 4848372. DOI: 10.5114/aoms.2016.59269. View

Garges H, Moody M, Cotten C, Smith P, Tiffany K, Lenfestey R . Neonatal meningitis: what is the correlation among cerebrospinal fluid cultures, blood cultures, and cerebrospinal fluid parameters?. Pediatrics. 2006; 117(4):1094-100. DOI: 10.1542/peds.2005-1132. View

Singhi P, Kaushal M, Singhi S, Ray P . Seven days vs. 10 days ceftriaxone therapy in bacterial meningitis. J Trop Pediatr. 2002; 48(5):273-9. DOI: 10.1093/tropej/48.5.273. View

Zea-Vera A, Ochoa T . Challenges in the diagnosis and management of neonatal sepsis. J Trop Pediatr. 2015; 61(1):1-13. PMC: 4375388. DOI: 10.1093/tropej/fmu079. View

10.

Okike I, Johnson A, Henderson K, Blackburn R, Muller-Pebody B, Ladhani S . Incidence, etiology, and outcome of bacterial meningitis in infants aged <90 days in the United kingdom and Republic of Ireland: prospective, enhanced, national population-based surveillance. Clin Infect Dis. 2014; 59(10):e150-7. DOI: 10.1093/cid/ciu514. View

11.

Lin T, Chrane D, Nelson J, McCracken Jr G . Seven days of ceftriaxone therapy is as effective as ten days' treatment for bacterial meningitis. JAMA. 1985; 253(24):3559-63. View

12.

Anderson S, Gilbert G . Neonatal gram negative meningitis: a 10-year review, with reference to outcome and relapse of infection. J Paediatr Child Health. 1990; 26(4):212-6. DOI: 10.1111/j.1440-1754.1990.tb02432.x. View

13.

Sudarsanam T, Rupali P, Tharyan P, Abraham O, Thomas K . Pre-admission antibiotics for suspected cases of meningococcal disease. Cochrane Database Syst Rev. 2008; (1):CD005437. DOI: 10.1002/14651858.CD005437.pub2. View

14.

Vergnano S, Sharland M, Kazembe P, Mwansambo C, Heath P . Neonatal sepsis: an international perspective. Arch Dis Child Fetal Neonatal Ed. 2005; 90(3):F220-4. PMC: 1721871. DOI: 10.1136/adc.2002.022863. View

15.

Koster-Rasmussen R, Korshin A, Meyer C . Antibiotic treatment delay and outcome in acute bacterial meningitis. J Infect. 2008; 57(6):449-54. DOI: 10.1016/j.jinf.2008.09.033. View

16.

Riordan A . Preventing meningitis and septicaemia: are we nearly there yet?. Lancet Infect Dis. 2014; 14(5):363-4. DOI: 10.1016/S1473-3099(14)70702-9. View

17.

Klinger G, Chin C, Beyene J, Perlman M . Predicting the outcome of neonatal bacterial meningitis. Pediatrics. 2000; 106(3):477-82. DOI: 10.1542/peds.106.3.477. View

18.

Martin E, Koup J, Paravicini U, Stoeckel K . Pharmacokinetics of ceftriaxone in neonates and infants with meningitis. J Pediatr. 1984; 105(3):475-81. DOI: 10.1016/s0022-3476(84)80032-3. View

19.

Okike I, Ribeiro S, Ramsay M, Heath P, Sharland M, Ladhani S . Trends in bacterial, mycobacterial, and fungal meningitis in England and Wales 2004-11: an observational study. Lancet Infect Dis. 2014; 14(4):301-7. DOI: 10.1016/S1473-3099(13)70332-3. View

20.

Tzialla C, Borghesi A, Perotti G, Garofoli F, Manzoni P, Stronati M . Use and misuse of antibiotics in the neonatal intensive care unit. J Matern Fetal Neonatal Med. 2012; 25 Suppl 4:35-7. DOI: 10.3109/14767058.2012.714987. View